磷脂市场 - 增长、趋势、COVID-19 影响和预测(2022-2027 年)
市场调查报告书
商品编码
1136087

磷脂市场 - 增长、趋势、COVID-19 影响和预测(2022-2027 年)

Phospholipids Market - Growth, Trends, and Forecasts (2022 - 2027)

出版日期: | 出版商: Mordor Intelligence | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计在 2022-2027 年的预测期内,磷脂市场的复合年增长率为 5.6%。

由于磷脂的多功能性,食品、补充剂和药品等各个行业对磷脂的需求不断增加。此外,丰富的原材料使製造商能够利用资源并扩大其产品组合。例如,2021 年,新西兰恆天然合作集团有限公司将推出 NZMP 牛奶磷脂 70,品牌名称为 NZMP。这种磷脂成分适用于各种食品和饮料产品,包括补充香囊、营养棒和即食保健粉,以在大流行期间放大的压力挑战下增强情绪和认知能力。

然后,由于对天然保健品的需求不断增加,磷脂成为营养保健品中一种很有前途的天然成分。此外,健康生活方式的日益普及,加上功能性食品和便利店消费的增加,进一步增加了对磷脂原料的需求,推动了预测期内的市场增长。

磷脂由于其乳化特性而被广泛用于食品和糖果中。婴儿配方奶粉也是磷脂应用增长最快的领域,因为它富含对婴儿营养至关重要的 DHA、ALA 和欧米茄脂肪酸。这些特性将对全球市场的磷脂原料产生积极影响。

主要市场趋势

在营养素和补充剂中的使用范围扩大

由于全球消费者对营养保健品的消费量不断增加,保健品行业对磷脂的需求也在增加。磷脂□丝氨酸主要用于大脑健康补充剂,因为它有助于改善认知功能。此外,最近的研究表明,服用磷脂□丝氨酸补充剂可能有益于患有註意力缺陷多动障碍的儿童和患有焦虑和压力的年轻人。此外,磷脂□丝氨酸因其健康益处而被广泛用于运动营养产品中,例如提高运动表现、促进疲劳恢復和防止肌肉酸痛。同样,磷脂□胆碱也被广泛用于婴儿配方奶粉,因为它富含二十二碳六烯酸和花生四烯酸,这对婴儿的生长至关重要。正因为如此,人群对基于磷脂的膳食补充剂的需求不断增加,进一步推动了磷脂原料市场的增长。

亚太地区正在蓬勃发展

由于各种应用行业的需求不断增加,预计亚太地区将成为磷脂市场增长最快的地区。由于食品和饮料製造业的高需求,中国在磷脂市场占有最大份额。此外,大豆、向日葵、鸡蛋、油菜籽和牛奶等原材料的丰富供应鼓励小型企业生产用于食品和保健品配方的天然原料。印度见证了以磷脂为基础的营养和健康补充剂的高采用率,因为它对健康有益,包括吸收 omega-3 脂肪酸,这反过来又推动了对磷脂的需求。

此外,製造商正在研发创新的磷脂配方,以应对新兴的最终用途细分市场,例如功能性食品。例如,2020 年 11 月,恆天然推出了一系列新的牛奶磷脂,包括用于功能性食品和饮料的 NZMP 牛奶磷脂,以管理压力的影响。随后,越来越多的年轻人口和不断增强的健康意识促使消费者寻求更好的替代品,例如食品补充剂。因此,它正在增加亚太地区磷脂的市场价值。此外,製药行业的持续扩张有望在未来几年为磷脂供应商提供有利可图的机会。

竞争格局

全球磷脂市场正在整合,开发营养成分的主要公司希望将业务扩展到食品、饮料、营养保健品和製药行业。 Cargill Inc.、Lipoid、Lecico GmbH、VAV 生命科学和 Novastell Ingredients Essentials 等公司在这个市场上运营。由于 FDA 法规的普遍性,大公司占据了上风并继续主导市场。该地区的主要公司将併购作为加强其产品组合、为更广泛的客户提供服务并扩展到未开发市场的战略。例如,2019 年,油和配料解决方案製造商 Avril Group 收购了磷脂製造商 Lecico GmbH,以扩大其在德国的业务。

其他福利。

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

内容

第1章介绍

  • 研究假设和市场定义
  • 调查范围

第2章研究方法

第 3 章执行摘要

第 4 章市场动态

  • 市场驱动力
  • 市场製约因素
  • 波特五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分

  • 按类型
    • 磷脂□丝氨酸
    • 磷脂□胆碱
    • 其他
  • 按供应来源
    • 大豆
    • 向日葵
    • 鸡蛋
    • 其他
  • 按用途
    • 食物和饮料
    • 营养补充剂
    • 药品
    • 其他
  • 区域信息
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
      • 北美其他地区
    • 欧洲
      • 英国
      • 德国
      • 西班牙
      • 法国
      • 意大利
      • 俄罗斯
      • 其他欧洲
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 其他亚太地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲
    • 中东和非洲
      • 沙特阿拉伯
      • 南非
      • 其他中东

第 6 章竞争格局

  • 最常采用的策略
  • 市场份额分析
  • 公司简介
    • Cargill Inc
    • Kewpie Corporation
    • Lasenor
    • Lipoid GmbH
    • Lecico gmbh
    • VAV life science
    • Novastell Ingredients Essentials
    • ECA Healthcare Inc.
    • Croda International Plc
    • CHEMI S.P.A.

第 7 章市场机会和未来趋势

第 8 章 COVID-19 对市场的影响

第9章免责声明

简介目录
Product Code: 92025

The Phospholipids market is projected to register a CAGR of 5.6% during the forecast period, 2022-2027.

The demand for phospholipids has been increasing in various industries including food, supplements, and pharmaceutical owing to their versatile property. In addition, the abundant availability of raw materials had enabled the manufacturers to utilize the resource and expand their product portfolio. For instance, in 2021, Fonterra Co-Operative Group Limited, the New Zealand company launched NZMP milk phospholipid 70 under the brand name NZMP. This phospholipid ingredient is suitable for various food and beverage products including supplement sachets, nutritional bars, and ready-to-mix health powders, and is specially formulated for mood enhancement and cognitive performance under stress issues that have been amplified during the pandemic period.

Subsequently, phospholipid is a promising natural ingredient for nutritional supplements products owing to the increasing demand for natural health supplements. In addition, the growing adoption of a healthy lifestyle coupled with increasing consumption of functional and convenience foods are further increasing the demand for phospholipid ingredients which in turn drives the market growth in the forecast period.

Owing to its emulsifying property, phospholipid has wide application in the food and confectionery industry. In addition, infant formula is the fastest growing application segment for phospholipids as it is rich in DHA, ALA, and omega fatty acids which are essential components for infant nutrition. This attribute will impact positively the phospholipid ingredients in the global market.

Key Market Trends

Increasing utilization in nutrients and supplements

The demand for phospholipids is increasing in the nutraceutical industry owing to the rising consumption of nutritional supplements among global consumers. Phosphatidylserine is majorly used in brain health supplements as it helps to boost cognitive function. Moreover, recent studies indicate that the consumption of phosphatidylserine supplements might act beneficial to children with attention deficit hyperactivity disorder and the young population suffering from anxiety and stress. In addition, Phosphatidylserine is widely utilized in sports nutrition products owing to its health benefits such as improving sports performance, speeding up recovery, and preventing muscle soreness. Similarly, Phosphatidylcholine is widely used in infant formula as it is enriched with docosahexaenoic acid and arachidonic acid which is essential for infant growth. Thereby, the increasing demand for phospholipid-based nutritional supplements among the population is further boosting the growth of the phospholipids ingredients market.

Asia-Pacific is the Fastest Growing Region

The Asia-Pacific region is anticipated to be the fastest-growing region for the phospholipids market due to its increasing demand in various application industries. China holds the largest share in the phospholipid market owing to its high demand in food and beverage manufacturing. Further, the abundant availability of raw materials such as soy, sunflower, egg, rapeseed, and milk is encouraging the small-scale players to produce naturally sourced ingredients for food and nutraceutical formulation. India has witnessed a higher adoption rate of phospholipid-based nutritional and health supplements due to its health benefits including the absorption of omega-3 fatty acids, which in turn, drives the demand for phospholipids.

Moreover, the manufacturers are engaged in formulating innovative phospholipids to cater to emerging end-use segments such as functional food products. For instance, in November 2020, Fonterra launched a new range of milk phospholipids including NZMP milk phospholipids for functional food & beverages to manage the effect of stress. Subsequently, the growing young population coupled with raising health consciousness has driven consumers to look up better alternatives such as food supplements. As a result, it strengthens the market value of phospholipids in the Asia-Pacific region. Additionally, the ongoing expansion of the pharmaceutical industry is anticipated to offer lucrative opportunities for phospholipid suppliers in the coming years.

Competitive Landscape

The global phospholipids market is consolidated as major players are coming up with nutritional ingredients in order to expand their reach in the food, beverage, nutraceuticals, and pharmaceutical industries. The players such as Cargill Inc., Lipoid, Lecico GmbH, VAV life science, and Novastell Ingredients Essentials among others are operating in the market. With prevalent FDA regulations, the leading players have an upper edge and continue to dominate the market. Major players in the region have been focusing on mergers and acquisitions as a strategy to strengthen their product portfolio, to cater a wide range of customers, and expand to untapped markets. For instance, in 2019, Avril Group, a manufacturer of oil and ingredient solutions acquired Lecico GmbH, a producer of phospholipids to expand their business activities in Germany.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Drivers
  • 4.2 Market Restraints
  • 4.3 Porter's Five Force Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Bargaining Power of Buyers/Consumers
    • 4.3.3 Bargaining Power of Suppliers
    • 4.3.4 Threat of Substitute Products
    • 4.3.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Type
    • 5.1.1 Phosphotidylserine
    • 5.1.2 Phosphotidylcholine
    • 5.1.3 Others
  • 5.2 By Source
    • 5.2.1 Soy
    • 5.2.2 Sunflower
    • 5.2.3 Egg
    • 5.2.4 Others
  • 5.3 By Application
    • 5.3.1 Food & beverage
    • 5.3.2 Nutraceutical Supplements
    • 5.3.3 Pharmaceuticals
    • 5.3.4 Others
  • 5.4 By Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
      • 5.4.1.4 Rest of North America
    • 5.4.2 Europe
      • 5.4.2.1 United Kingdom
      • 5.4.2.2 Germany
      • 5.4.2.3 Spain
      • 5.4.2.4 France
      • 5.4.2.5 Italy
      • 5.4.2.6 Russia
      • 5.4.2.7 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 Rest of Asia-Pacific
    • 5.4.4 South America
      • 5.4.4.1 Brazil
      • 5.4.4.2 Argentina
      • 5.4.4.3 Rest of South America
    • 5.4.5 Middle East & Africa
      • 5.4.5.1 Saudi Arabia
      • 5.4.5.2 South Africa
      • 5.4.5.3 Rest of Middle East & Africa

6 COMPETITIVE LANDSCAPE

  • 6.1 Most Adopted Strategies
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles
    • 6.3.1 Cargill Inc
    • 6.3.2 Kewpie Corporation
    • 6.3.3 Lasenor
    • 6.3.4 Lipoid GmbH
    • 6.3.5 Lecico gmbh
    • 6.3.6 VAV life science
    • 6.3.7 Novastell Ingredients Essentials
    • 6.3.8 ECA Healthcare Inc.
    • 6.3.9 Croda International Plc
    • 6.3.10 CHEMI S.P.A.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

8 IMPACT OF COVID-19 ON THE MARKET

9 DISCLAIMER